COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER
A new combined treatment scheme with short-course chemoradiotherapy and 2 selective radiosensitizers (metronidazole in a polymeric composition and local hyperthermia) is investigated in this article.Material and methods. 77 T1–3N0–2M0 rectal cancer patients treatment data was analyzed. All patients...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
“ABV-press” Publishing house”, LLC
2015-02-01
|
| Series: | Тазовая хирургия и онкология |
| Subjects: | |
| Online Access: | https://ok.abvpress.ru/jour/article/view/76 |
| _version_ | 1797705418181443584 |
|---|---|
| author | Yu. A. Barsukov D. V. Kuzmichev S. I. Tkachev V. A. Aliev R. I. Tamrazov A. G. Malikhov Z. Z. Mamedli I. Sh. Tataev O. A. Vlasov S. S. Gordeev |
| author_facet | Yu. A. Barsukov D. V. Kuzmichev S. I. Tkachev V. A. Aliev R. I. Tamrazov A. G. Malikhov Z. Z. Mamedli I. Sh. Tataev O. A. Vlasov S. S. Gordeev |
| author_sort | Yu. A. Barsukov |
| collection | DOAJ |
| description | A new combined treatment scheme with short-course chemoradiotherapy and 2 selective radiosensitizers (metronidazole in a polymeric composition and local hyperthermia) is investigated in this article.Material and methods. 77 T1–3N0–2M0 rectal cancer patients treatment data was analyzed. All patients received 5 Ч 5 Gy radiotherapy with capecitabine 1300 mg/m2 days 1–5 per os and radiosensitization with local hyperthermia and metronidazole.Results. Investigated treatment scheme has acceptable toxicity and leads to high local control rate (none of the patients experienced local recurrence). 7 (9.1 %) patients developed distant metastases. 59 (76.6 %) patients had sphincter-sparing surgery. Median followup was 65.6 months. 5-year survival rate was 81.7 %.Conclusion. Developed treatment scheme is safe and leads to high local control rate. |
| first_indexed | 2024-03-12T05:36:55Z |
| format | Article |
| id | doaj.art-d35588090785466d89ed8740f40ba36a |
| institution | Directory Open Access Journal |
| issn | 2686-9594 |
| language | Russian |
| last_indexed | 2024-03-12T05:36:55Z |
| publishDate | 2015-02-01 |
| publisher | “ABV-press” Publishing house”, LLC |
| record_format | Article |
| series | Тазовая хирургия и онкология |
| spelling | doaj.art-d35588090785466d89ed8740f40ba36a2023-09-03T06:24:43Zrus“ABV-press” Publishing house”, LLCТазовая хирургия и онкология2686-95942015-02-0103232810.17650/2220-3478-2014-0-3-23-2870COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCERYu. A. Barsukov0D. V. Kuzmichev1S. I. Tkachev2V. A. Aliev3R. I. Tamrazov4A. G. Malikhov5Z. Z. Mamedli6I. Sh. Tataev7O. A. Vlasov8S. S. Gordeev9N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowN.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowA new combined treatment scheme with short-course chemoradiotherapy and 2 selective radiosensitizers (metronidazole in a polymeric composition and local hyperthermia) is investigated in this article.Material and methods. 77 T1–3N0–2M0 rectal cancer patients treatment data was analyzed. All patients received 5 Ч 5 Gy radiotherapy with capecitabine 1300 mg/m2 days 1–5 per os and radiosensitization with local hyperthermia and metronidazole.Results. Investigated treatment scheme has acceptable toxicity and leads to high local control rate (none of the patients experienced local recurrence). 7 (9.1 %) patients developed distant metastases. 59 (76.6 %) patients had sphincter-sparing surgery. Median followup was 65.6 months. 5-year survival rate was 81.7 %.Conclusion. Developed treatment scheme is safe and leads to high local control rate.https://ok.abvpress.ru/jour/article/view/76rectal cancercombination therapylocal ultrahigh-frequency hyperthermiametronidazolesystemic chemotherapysphinctersparing surgery |
| spellingShingle | Yu. A. Barsukov D. V. Kuzmichev S. I. Tkachev V. A. Aliev R. I. Tamrazov A. G. Malikhov Z. Z. Mamedli I. Sh. Tataev O. A. Vlasov S. S. Gordeev COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER Тазовая хирургия и онкология rectal cancer combination therapy local ultrahigh-frequency hyperthermia metronidazole systemic chemotherapy sphinctersparing surgery |
| title | COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER |
| title_full | COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER |
| title_fullStr | COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER |
| title_full_unstemmed | COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER |
| title_short | COMBINATION NEOADJUVANT THERMOCHEMICAL THERAPY IN PATIENTS WITH RECTAL CANCER |
| title_sort | combination neoadjuvant thermochemical therapy in patients with rectal cancer |
| topic | rectal cancer combination therapy local ultrahigh-frequency hyperthermia metronidazole systemic chemotherapy sphinctersparing surgery |
| url | https://ok.abvpress.ru/jour/article/view/76 |
| work_keys_str_mv | AT yuabarsukov combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT dvkuzmichev combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT sitkachev combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT vaaliev combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT ritamrazov combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT agmalikhov combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT zzmamedli combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT ishtataev combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT oavlasov combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer AT ssgordeev combinationneoadjuvantthermochemicaltherapyinpatientswithrectalcancer |